html5-img
1 / 1

Interstitial Cystitis Market

The total diagnosed prevalent population of Interstitial Cystitis in the 7MM was 2,264,118 in 2017. The diagnosed prevalent cases of Interstitial Cystitis in the United States were found to be 1,459,502 in 2017. It is observed that womens are more affected with IC as compared to males.<br><br>The market size of Interstitial Cystitis in the 7MM was USD 1,599 Million in 2017, which is expected to increase during the forecast period 2017-2030.<br><br>FDA approved oral medication, increasing emerging therapies, increasing awareness are some of the key factors expected to drive the IC market in the coming years. <br><br>The key companies in the therapeutics market of Interstitial Cystitis includes KYORIN Pharmaceutical, UCB, Gru00fcnenthal, Astellas Pharma, Lipella Pharmaceuticals, SEIKAGAKU CORPORATION and many others. <br><br>For more information visit: https://www.delveinsight.com/report-store/interstitial-cystitis-market

DelveInsight
Télécharger la présentation

Interstitial Cystitis Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related